Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrence × Brachytherapy × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 13 Prostatic Neoplasms 12 Neoplasms 4 Breast Neoplasms 3 Vaginal Neoplasms 2 Uterine Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Endometrial Clear Cell Adenocarcinoma 2 Vulvar Neoplasms 1 Stage IA Uterine Sarcoma 1 Radiation Injuries 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Obesity 1 Neurotoxicity Syndromes 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Locally Advanced Cervical Cancer 1 Liver Neoplasms 1 Fatigue 1 Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1 Endometrial Adenocarcinoma 1 Desmoplastic Small Round Cell Tumor 1 Cholangiocarcinoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1 Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 32 Dexamethasone 30 Rituximab 22 Cytarabine 21 fludarabine phosphate 20 Methotrexate 17 Lenalidomide 17 fludarabine 15 Bortezomib 15 Peripheral Blood Stem Cell Transplantation 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 Mycophenolic Acid 13 Etoposide 13 pembrolizumab 12 Melphalan 12 Filgrastim 12 Paclitaxel 11 Gemcitabine 11 Cyclosporine 11 Carboplatin 11 pomalidomide 10 Busulfan 10 Vincristine 9 carfilzomib 8 Tacrolimus 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Brentuximab Vedotin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡